FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:667-678 August 26, 1999 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Diabetic retinopathy has been and probably remains one of the four major causes of blindness in the United States.^1,2 The risk of retinopathy is directly related to the degree and duration of hyperglycemia.³ After diabetes mellitus has been present for 20 years, almost all persons in whom the onset of diabetes occurred before the age of 30 years have some evidence of retinopathy, and about half have proliferative retinopathy. Persons who are 30 years of age or older when diabetes develops are at lower risk for retinopathy, but in this group retinopathy may be the first sign of diabetes. In . . . [Full Text of this Article]

Clinical Manifestations

Prevention

Photocoagulation

Vitrectomy

Conclusions

Source Information

From the National Eye Institute, National Institutes of Health, Bethesda, Md. (F.L.F.); the Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison (M.D.D.); and Beetham Eye Institute, Joslin Diabetes Center, Boston (L.M.A.).

Address reprint requests to Dr. Ferris at the Division of Biometry and Epidemiology, 31 Center Dr., MSC-2510, Bldg. 31, Rm. 6A52, Bethesda, MD 20892-2510, or at rickferris@nei.nih.gov.

References

This article has been cited by other articles:

• Ohno, T., Takamoto, S., Motomura, N. (2008). Diabetic Retinopathy and Coronary Artery Disease From the Cardiac Surgeon's Perspective. Ann. Thorac. Surg. 85: 681-689 [Abstract] [Full Text]  
• Wagner, H., Pizzimenti, J. J., Daniel, K., Pandya, N., Hardigan, P. C. (2008). Eye on Diabetes: A Multidisciplinary Patient Education Intervention. The Diabetes Educator 34: 84-89 [Abstract] [Full Text]  
• Forooghian, F., Razavi, R., Timms, L. (2007). Hypoxia-inducible factor expression in human RPE cells. Br. J. Ophthalmol. 91: 1406-1410 [Abstract] [Full Text]  
• Van den Berghe, G., Wilmer, A., Milants, I., Wouters, P. J., Bouckaert, B., Bruyninckx, F., Bouillon, R., Schetz, M. (2006). Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units: Benefit Versus Harm. Diabetes 55: 3151-3159 [Abstract] [Full Text]  
• Gholap, N., Pillai, M., Virmani, S., Lee, J. D, James, D., Morrissey, J., Datta, V., Patel, V. (2006). The Alphabet Strategy and standards of care in young adults with type 1 diabetes. British Journal of Diabetes & Vascular Disease 6: 168-170 [Abstract]  
• Watts, L. M., Manchem, V. P., Leedom, T. A., Rivard, A. L., McKay, R. A., Bao, D., Neroladakis, T., Monia, B. P., Bodenmiller, D. M., Cao, J. X.-C., Zhang, H. Y., Cox, A. L., Jacobs, S. J., Michael, M. D., Sloop, K. W., Bhanot, S. (2005). Reduction of Hepatic and Adipose Tissue Glucocorticoid Receptor Expression With Antisense Oligonucleotides Improves Hyperglycemia and Hyperlipidemia in Diabetic Rodents Without Causing Systemic Glucocorticoid Antagonism. Diabetes 54: 1846-1853 [Abstract] [Full Text]  
• Ferris, F. L. III (2004). A New Treatment for Ocular Neovascularization. NEJM 351: 2863-2865 [Full Text]  
• Lee, D. J., Gomez-Marin, O., Lam, B. L., Zheng, D. D., Jane, D. M. (2004). Trends in Visual Acuity Impairment in US Adults: The 1986-1995 National Health Interview Survey. Arch Ophthalmol 122: 506-509 [Abstract] [Full Text]  
• Frank, R. N. (2004). Diabetic Retinopathy. NEJM 350: 48-58 [Full Text]  
• Donnelly, R, Idris, I, Forrester, J V (2004). Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research. Br. J. Ophthalmol. 88: 145-151 [Abstract] [Full Text]  
• Gerl, V. B., Bohl, J., Pitz, S., Stoffelns, B., Pfeiffer, N., Bhakdi, S. (2002). Extensive Deposits of Complement C3d and C5b-9 in the Choriocapillaris of Eyes of Patients with Diabetic Retinopathy. IOVS 43: 1104-1108 [Abstract] [Full Text]  
• Gao, G., Li, Y., Fant, J., Crosson, C. E., Becerra, S. P., Ma, J.-x. (2002). Difference in Ischemic Regulation of Vascular Endothelial Growth Factor and Pigment Epithelium--Derived Factor in Brown Norway and Sprague Dawley Rats Contributing to Different Susceptibilities to Retinal Neovascularization. Diabetes 51: 1218-1225 [Abstract] [Full Text]  
• Shea, S., Starren, J., Weinstock, R. S., Knudson, P. E., Teresi, J., Holmes, D., Palmas, W., Field, L., Goland, R., Tuck, C., Hripcsak, G., Capps, L., Liss, D. (2002). Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) Project: Rationale and Design. J. Am. Med. Inform. Assoc. 9: 49-62 [Abstract] [Full Text]  
• Cooper, D. S., DeAngelis, C. D. (2001). Diabetes Mellitus--A Call for Papers. JAMA 286: 968-969 [Full Text]  
• Murata, T., Hata, Y., Ishibashi, T., Kim, S., Hsueh, W. A., Law, R. E., Hinton, D. R. (2001). Response of Experimental Retinal Neovascularization to Thiazolidinediones. Arch Ophthalmol 119: 709-717 [Abstract] [Full Text]  
• Olefsky, J. M. (2001). Prospects for Research in Diabetes Mellitus. JAMA 285: 628-632 [Abstract] [Full Text]  
• Ong, H. T., Kajubi, S. K. (2000). Aspirin in Diabetes: Beware of Retinopathy. Arch Intern Med 160: 3004-3004 [Full Text]  
• Zander, E., Herfurth, S., Bohl, B., Heinke, P., Herrmann, U., Kohnert, K.-D., Kerner, W. (2000). Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors. Br. J. Ophthalmol. 84: 871-876 [Abstract] [Full Text]